基本信息
views: 7

Bio
Dr. Shuguang Hou is the Chairman and CEO of Sichuan Purity Pharmaceutical Co. Ltd(“Purity Pharma”). He also works as a professor and a Ph.D. student advisor at Chengdu University of TCM. He obtained a BS degree in pharmacy from Beijing Medical University in 1991, and a Ph.D. degree in pharmaceutical sciences from Virginia Commonwealth University in USA in 2001. He worked as a teaching assistant at Beijing Medical University, a research scientist at PPD Development in USA, and a product development specialist and APAC technical business marketing manager at 3M in USA. He returned China in 2012 and established Purity Pharma. Purity Pharma has a full R&D pipeline with more 30 drug products, and 6 approved products on market. He has published more than 30 scientific papers, co-translated and co-authored 3 books, and honored 18 patents. He received more than 10 national and international awards.
Research Interests
Papers共 12 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Juan Guo, Zhongtang Chen, Rong Huang,Dandan Tang, Yuhuan Wang,Pan Song, Liangyu Mei,Shuguang Hou,Wei Peng,Lisha He,Qiang Ren
INTERNATIONAL JOURNAL OF PHARMACEUTICS-X (2024)
Arabian Journal of Chemistryno. 3 (2023): 105594-105594
Cited0Views0Bibtex
0
0
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2023)
LI Ling-hui,LIAO Wan, ZHANG Qian,YU Fang-kun,TAN Li-wei, LI Zhang-cai,HU Qiong-dan,ZHANG Xin-jie,LIAO Yang-yang,HOU Shu-guang, LI Rui
Journal of Pharmaceutical Sciencesno. 7 (2022): 2107-2115
Load More
Author Statistics
#Papers: 12
#Citation: 12
H-Index: 2
G-Index: 3
Sociability: 4
Diversity: 2
Activity: 6
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn